Data centre operators say the Albanese government’s new expectations, which are meant to help the development of critical infrastructure needed for artificial intelligence and cloud computing, are so ...

New clinical data from Phase 1 trial of ZW191 to be presented in an oral presentation on April 21 Preclinical data highlight combination potential for ZW191, a folate receptor alpha (FR⍺)-targeting ...

New clinical data from Phase 1 trial of ZW191 to be presented in an oral presentation on April 21 Preclinical data highlight combination potential for ZW191, a folate receptor alpha (FR ⍺)-targeting ...

Connecting the dots: Will Oracle be the first major company to falter amid the looming AI bubble? Analysts are scrambling to interpret what is really happening at the cloud giant, as co-founder Larry ...

Global ETF flows captured an annual record USD 1.5 trillion for the calendar year. Investors’ “risk on” posture was evident throughout the year in exchange-traded fund flows and was further amplified ...

SOUTH SAN FRANCISCO, Calif., Jan. 07, 2026 (GLOBE NEWSWIRE) -- BridgeBio Oncology Therapeutics, Inc. (“BBOT”) (Nasdaq: BBOT), a clinical-stage biopharmaceutical company focused on RAS-pathway ...

WASHINGTON, Nov 18 (Reuters) - A divided U.S. Federal Reserve begins receiving updated economic reports from the now-reopened federal government this week as policymakers hope for clarity in their ...

Flow cytometry is a key diagnostic technique in hematology that provides protein information at a single-cell level. Traditionally interpreted manually in a sequence of two-dimensional plots, ...

The number of biopharma M&A deals announced so far this year is higher than the yearly average for the last 15 years, while deal value has already eclipsed last year’s total. For 2025, a mean of 21 ...

Mark Lipacis, Evercore ISI analyst, joins CNBC's 'The Exchange' to discuss why he's bullish on Texas Instruments. Got a confidential news tip? We want to hear from you. Sign up for free newsletters ...